Sort
8,912 grants matching “sars cov 2”
How S. aureus protein SSL11 inhibits neutrophil migration
$21,138Chen Chen · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM
RAPID: Behavioral Drivers and Social Pathways in the Spread of the COVID-19 Omicron Variant
$20,884Amy E Stambach · University Of Wisconsin-Madison · · FY2022 · SBE
Task V25: PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS-COV-2
$20,462Andreas Neubert · Idt Biologika Gmbh · N01 · FY2020 · AI
V25: PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS-COV-2
$20,264Thomas Hassel · International Aids Vaccine Initiative · N01 · FY2020 · AI
Diversity Supplement: Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI
$19,862Daniel Kim · Northwestern University At Chicago · R01 · FY2024 · HL
Anticytokine Autoantibodies in COVID-19
$19,619Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
immune regulation by helminths and the microbiota with SARS-Cov2 infection
$19,454P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
COVID-19 Animal Testing Capacity
$19,256Eman Anis · University Of Pennsylvania · U18 · FY2022 · FD
Role of interferon lambda in host protection during aging
$18,850Rudragouda Channappanavar · University Of Iowa · R21 · FY2018 · AG
Microbial Dysbiosis and Epithelial Dysfunction in Vitamin A-deficient Lungs
$18,707Kiloni Quiles · Boston University Medical Campus · F31 · FY2024 · HL
Novel SARS-CoV-2 vaccine candidates: Live, recombinant Leishmania
$18,682David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Antagonism of Coronavirus Spike Proteins by Cellular Host Factors
$18,681Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Monkeypox vaccines and monoclonal antibodies
$18,581Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Cell biology of SARS-CoV-2 infection
$18,479Ted Hackstadt · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Serologic studies of persons with COVID-19 infection
$18,059Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
$17,810Arjun Rustagi · Stanford University · K08 · FY2024 · AI
SARS-CoV2 infection in the intestine
$17,750Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Monoclonal antibody isolation and characterization for COVID-19 Effort
$17,731Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
HIV and (Re)Emerging Viruses: Aligning Lessons Across Pandemics
$17,700Terry L. Sheppard · Keystone Symposia · R13 · FY2024 · AI
RAPID: Identifying New ACE2 Receptor-Protein Interactions Using Evolutionary Inference
$17,361John H Werren · University Of Rochester · · FY2020 · BIO
A full-length cDNA clone of SARS-CoV-2.
$16,970Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Identification of co-receptor and components involved in the entry of SARS-CoV-2 using a quantitative phosphoproteomic approach
$16,675Tian Jin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Delivery of Nucleic Acid Therapeutics
$16,500Terry L. Sheppard · Keystone Symposia · R13 · FY2024 · TR
Zotatifin treatment of adults with mild to moderate COVID-19
$16,385Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study
$16,344Stephen John Gange · Johns Hopkins University · U01 · FY2021 · HL